Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-06-26

Clinical Trial Update: Powder Topical Rifampicin on Reducing Infections After Neural Tube Defect Surgery in Infants

View source ↗

Summary

A clinical trial is evaluating whether powder topical rifampicin reduces postoperative infections after neural tube defect surgery in infants; the current trial…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Powder Topical Rifampicin (rifampicin)

Snippet

Sponsor: Yuzuncu Yil University | Conditions: Postoperative Infection Rates | Status: UNKNOWN